Stocks · Health care · Pharmaceutical Preparations

Xenon Pharmaceuticals Inc.

XENE Clue Score32
British Columbia, Canada Fiscal year ends December CIK 0001582313 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ian Mortimer
30 Sep 2026
President & CEO
Buy
30,000
$37.38
$1.12M
Thomas Patrick Kelly
30 Sep 2026
Chief Financial Officer
Buy
15,000
$37.32
$559.74K

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 11
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 402,491
History held since 6 Nov 2014